NYSE:RFL
Rafael Holdings, Inc. Stock News
$1.53
+0 (+0%)
At Close: May 31, 2024
Rafael Holdings Appoints Patrick Fabbio as Chief Financial Officer
08:27am, Tuesday, 14'th Sep 2021
NEWARK, N.J., Sept. 14, 2021 /PRNewswire/ -- Rafael Holdings, Inc., (NYSE: RFL), a pharmaceutical holding company focused on developing novel cancer metabolism therapeutics through its Barer Institut
New York, New York--(Newsfile Corp. - August 26, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All Persons or Entities who purchased Rafael Holdings, Inc. ("Rafael Holdi
CRANBURY, N.J., Aug. 25, 2021 (GLOBE NEWSWIRE) -- -- Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, today anno
Rafael Holdings Announces Closing of $104.2 Million Private Placement
04:01pm, Tuesday, 24'th Aug 2021
NEWARK, N.J., Aug. 24, 2021 /PRNewswire/ -- Rafael Holdings, Inc. (NYSE: RFL) today announced the closing of the previously announced private investment in public equity (PIPE) financing.
Rafael Holdings Announces $104.2 Million Private Placement
07:00am, Friday, 20'th Aug 2021
NEWARK, N.J., Aug. 20, 2021 /PRNewswire/ -- Rafael Holdings, Inc. (NYSE: RFL) today announced that it has entered into definitive agreements to sell securities in a private placement that is expecte
NEWARK, N.J., Aug. 17, 2021 /PRNewswire/ -- Rafael Holdings, Inc., (NYSE: RFL), a pharmaceutical company focused on developing novel cancer metabolism therapeutics, today announced the appointment of
RAFAEL (RFL) STOCKHOLDER ALERT - Andrews & Springer LLC Is Seeking More Cash for Shareholders of Rafael Holdings, Inc.
08:01am, Monday, 16'th Aug 2021
WILMINGTON, Del.--(BUSINESS WIRE)--Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary d
FDA Grants Rafael Pharmaceuticals Orphan Drug Designation for CPI-613® (Devimistat) for Treatment of Biliary Cancer
11:00am, Tuesday, 29'th Jun 2021
Company reaches important milestone to advance potential novel therapy for this subset of gastrointestinal cancers Company reaches important milestone to advance potential novel therapy for this subse
Philadelphia, Pennsylvania--(Newsfile Corp. - June 28, 2021) - Kaskela Law LLC announces that it is investigating Rafael Holdings, Inc. ("Rafael Holdings") (NYSE: RFL) on behalf of the company's stock
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Rafael Pharm
NEWARK, N.J. and CRANBURY N.J.
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of Rafael Holdings, Inc. (“Holdings”) (NYSE: RFL) and Rafael Pharmaceuticals, In
Rafael Holdings Announces Strategic Merger with Rafael Pharmaceuticals to Form a Focused Late-Stage Clinical Oncology Company
06:30am, Monday, 21'st Jun 2021
NEWARK, N.J. and CRANBURY, N.J.
Rafael Holdings Appoints Three Highly Experienced Biopharmaceutical Leaders to its Board of Directors
04:45pm, Monday, 14'th Jun 2021
NEWARK, N.J., June 14, 2021 /PRNewswire/ -- Rafael Holdings, Inc., (NYSE: RFL), a pharmaceutical company focused on developing novel cancer metabolism therapeutics, today announced the appointment of
Rafael Holdings Announces Inducement Grant Under NYSE Rule 303A.08
04:30pm, Friday, 28'th May 2021
NEWARK, N.J., May 28, 2021 /PRNewswire/ -- Rafael Holdings, Inc., (NYSE: RFL), today announced that, on May 27, 2021, it made a grant to Ameet Mallik, Rafael Holdings' Chief Executive Officer, of 908
